Latigo Biotherapeutics LTGO recently raised US 345.6 million in its IPO, offering 19,200,000 common shares at US 18 each, following publication in the New England Journal of Medicine of clinical data for its lead non opi
LTGO (LTGO) โ Live Session & Technical Brief
Updated Nov 22, 2026 6:53 AM ET ยท Prev Close $13.24
Session Regime & Catalyst Assessment
64% Signal ConvictionControlled Session Consolidation (-1.81%) in Equities
Ltgo (Ltgo) is trading within a tight intraday band at $13.00 (-1.81%, 0.92x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, LTGO is outperforming the S&P 500 by +1.83%. 14-day RSI stands at 41.4, keeping momentum in a bearish regime.
Latigo Biotherapeutics LTGO recently raised US 345.6 million in its IPO, offering 19,200,000 common shares at US 18 each, following publication in the New England Journal of Medicine of clinical data for its lead non opi
Price ($13.00) trades relative to 20-day SMA ($13.78) and 50-day SMA ($16.07).
Market & Sector Relative Strength
LTGO outperforming the S&P 500 by +1.83%Recent LTGO Catalyst Headlines
Verified WirePhase 3 bunionectomy and open-label safety trials of onzotrigine remain on track for initiation with topline results expected in the second half of 2027 Company plans to add oxycodone acetaminophen commonly known as Perc
Todd N. Smith, a seasoned executive with deep experience commercializing pain therapies, appointed as president and chief executive officer to lead Latigo through planned late-stage development and commercialization of t
Thousand Oaks, Calif., Nov. 03, 2026 Globe Newswire -- Latigo Biotherapeutics, Inc. Nasdaq LTGO , a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines, today announced t
1โ3 Day Expected Range & Key Level
54% Follow-ThroughMonitor volume expansion above 1.5x RVOL around $13.78 (20-day SMA resistance) for directional breakout confirmation.
Technical Regime (LTGO)
BEARISH MA TRENDAbout LTGO
Get Instant LTGO Catalyst Alerts
Receive an email alert when LTGO triggers an unusual volume breakout, options sweep, or rating shift.
LTGO Session & Catalyst FAQ
Why is LTGO stock trading near flat today?
Ltgo (Ltgo) is trading within a tight intraday band at $13.00 (-1.81%, 0.92x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, LTGO is outperforming the S&P 500 by +1.83%. 14-day RSI stands at 41.4, keeping momentum in a bearish regime.
Is LTGO stock a buy or sell right now?
Today's session carries a 64% catalyst conviction score on 0.92x relative volume (moderate participation). Our multi-factor model currently rates LTGO as BUY. Review full valuation, quality, and timing signals on the LTGO Buy or Sell Decision Brief โ
What is LTGO's intrinsic value and expected trading range?
At $13.00, LTGO's modeled 1-to-3 session range is $12.45 โ $13.55, with a key inflection level at $13.78 (20-day SMA resistance). Compare current price against multi-year cash flow projections in the LTGO Intrinsic Value & DCF Model โ and Market Cycle Phase Tracker โ
What do RSI and moving averages signal for LTGO?
RSI at 41.4 reflects soft below-midline momentum. LTGO trades at $13.00 relative to its 20-day SMA ($13.78) and 50-day SMA ($16.07), reflecting a bearish moving-average structure.
Tradestie Flagship Research & Market Hubs
Live institutional catalyst tape ranking liquid gainers, losers, options sweeps, and RVOL surges.
Track spot H100/B200 compute rental rates and frontier LLM inference token economics.
Wafer yield, CoWoS packaging, and HBM bill-of-materials teardown models across AI accelerators.
Monitor engineering velocity and upstream foundry wafer demand inflections across tech leaders.
Live conviction tracking, invalidation guardrails, and thesis health checks on flagship ideas.
Backtest-validated unusual options positioning and open-interest accumulation setups.
Daily ranked quantitative leaderboard with audited forward-return track record vs S&P 500.
High-yield, quality-screened cash-secured put and put-spread income candidates.